5[beta]-reductase (AKR1D1) is downregulated in patients with non-alcoholic fatty liver disease and protects against hepatocellular carcinoma cell proliferation in vitro (2019)
Attributed to:
Dissecting the steroid metabolome in the pathogenesis and treatment of metabolic liver disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1530/endoabs.65.oc1.4
Publication URI: http://dx.doi.org/10.1530/endoabs.65.oc1.4
Type: Journal Article/Review
Parent Publication: Endocrine Abstracts